Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat VEGFB ELISA Kit (AC3935)
Cat.#: ASET-2524
Specifications
Description Rat VEGFB ELISA Kit allows for the in vitro quantitative determination of rat VEGFB concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1464 Human L1CAM ELISA Kit (AC2875) Quantitative inquiry ASET-1295 Human NPFF2 Receptor ELISA Kit (AC2706) Quantitative inquiry ASET-1428 Sheep Myelin Basic Protein ELISA Kit (AC2839) Quantitative inquiry ASET-1398 Human nNOS (neuronal) ELISA Kit (AC2809) Quantitative inquiry ASET-1308 Human Eph Receptor A2 ELISA Kit (AC2719) Quantitative inquiry ASET-1900 Human Drebrin ELISA Kit (AC3311) Quantitative inquiry ASET-2068 Mouse LIF ELISA Kit (AC3479) Quantitative inquiry ASET-1655 Rat GDNF ELISA Kit (AC3066) Quantitative inquiry ASET-1071 Human TMPRSS2 ELISA Kit (AC2482) Quantitative inquiry ASET-1851 Human APC ELISA Kit (AC3262) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket